Cue Biopharma, Inc. Quarterly Interest Expense in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cue Biopharma, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2021 to Q1 2024.
  • Cue Biopharma, Inc. Interest Expense for the quarter ending March 31, 2024 was $33K, unchanged year-over-year.
  • Cue Biopharma, Inc. Interest Expense for the twelve months ending March 31, 2024 was $130K, a 11.1% increase year-over-year.
  • Cue Biopharma, Inc. annual Interest Expense for 2023 was $130K, a 19.3% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $130K $33K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $130K -$507K -$525K -2917% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $655K $254K +$221K +670% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $434K $350K +$317K +961% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $117K $33K +$8K +32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $109K $18K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $33K +$33K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $33K +$33K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $25K +$25K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.